Remission InductionRemission, SpontaneousCytarabineAntineoplastic Combined Chemotherapy ProtocolsLeukemia, Myeloid, AcuteTreatment OutcomeRecurrenceVincristineCyclophosphamidePrecursor Cell Lymphoblastic Leukemia-LymphomaDaunorubicinPrednisoneCombined Modality TherapyTransplantation, AutologousLeukemia, MyeloidDisease-Free SurvivalPrognosisEtoposidePrednisoloneHematopoietic Stem Cell TransplantationDoxorubicinIdarubicinMethotrexateBone Marrow TransplantationFollow-Up StudiesSurvival AnalysisLymphoma, Non-HodgkinLeukemia, Promyelocytic, AcuteTransplantation, HomologousNeoplasm, ResidualHodgkin DiseaseSalvage TherapySurvival RateAcute DiseaseAsparaginaseLeukemia, LymphoidDrug Administration ScheduleBleomycinAntineoplastic AgentsAntibodies, Monoclonal, Murine-DerivedBone MarrowThioguanineLeukemiaProcarbazineMechlorethamineCladribineRetrospective StudiesNephrotic Syndrome6-MercaptopurineTime FactorsImmunosuppressive AgentsVidarabineTransplantation ConditioningMelphalanDrug Therapy, CombinationAnemia, Refractory, with Excess of BlastsGraft vs Host DiseaseActuarial AnalysisVinblastineProspective StudiesAntibodies, MonoclonalChlorambucilNeoplasm Recurrence, LocalMyelodysplastic SyndromesOxidesWhole-Body IrradiationLymphomaLymphoma, Large B-Cell, DiffuseMultiple MyelomaLymphoma, FollicularArsenicalsMitoxantroneBone Marrow PurgingConsolidation ChemotherapyStem Cell TransplantationDrug EvaluationColitis, UlcerativeBusulfanLeukemia, Hairy CellArabinonucleosidesKaryotypingGlomerulonephritis, MembranousLeukocyte CountAntirheumatic AgentsNeoplasm StagingLeukemia, Myelomonocytic, AcuteTranslocation, GeneticLymphoma, B-CellMesalamineAmsacrineInfusions, IntravenousCisplatinPentostatinClinical Trials as TopicLeukemia, Myelogenous, Chronic, BCR-ABL PositivePhiladelphia ChromosomeCytogenetic AnalysisCyclosporinePulse Therapy, DrugBlast Crisis